ConAgra Brands Inc. stocks have been trading down by -3.26 percent after weak earnings and cautious forward guidance dampened sentiment.
What Traders Need To Know
- Q4 FY26 showed 3.6% net sales growth but flat organic revenue, weaker margins at 11.7%, and adjusted EPS of $0.47, capping a year of falling sales, earnings, cash flow, and EBITDA.
- Roughly $2.0B in goodwill and brand impairments drove a large GAAP loss and forced a reset of the annual dividend down to $0.70 per share.
- Fiscal 2027 guidance calls for adjusted EPS of $1.40–$1.50, below Street expectations near $1.56–$1.58, with a 1–3% organic net sales decline and operating margins slipping to 10.0–10.5%.
- Shares dropped more than 5–6% after the weak outlook and dividend cut, as the market repriced ConAgra Brands Inc. for lower earnings power.
- RBC cut its price target from $16 to $14, calling FY27 an execution-heavy rebuilding year during a CEO transition.
Weekly Update Jul 27 – Jul 31, 2026: On Friday, July 31, 2026 ConAgra Brands Inc. stock [NYSE: CAG] is trending down by -3.26%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Consumer Staples industry expert:
Analyst sentiment – negative
Conagra’s current fundamentals are weak relative to both its own history and packaged-food peers. A 23.9% gross margin is acceptable, but deeply negative EBIT and EBITDA margins reflect heavy $2.0B impairment charges and poor recent execution, driving LTM ROE around -25% and ROIC near -10%. Revenue is essentially flat over five years, signaling limited organic growth. On valuation, 0.66x sales and ~3.8x FCF look optically cheap, but leverage (TD/E 1.1x, ~3.8–4.0x EBITDA) and a sub-1x current ratio constrain flexibility. Critically, Conagra still generated ~$400M quarterly FCF even in a reset year, supporting the reduced dividend and internal reinvestment.
On the technical side, weekly price action shows a clear short-term downtrend, with the stock breaking from $15.50 toward $14.50 on heavy post-guidance volume, confirming institutional selling. Intraday 5‑minute candles show failed bounces above $15 and supply emerging quickly into strength. The dominant pattern is lower highs with support forming near $14.40–14.50. For tactical traders, $14.40 is the key actionable level: a break and sustained trade below favors a short bias, while aggressive longs should only engage above $15.50 with tight risk controls.
The recent news flow is decisively negative: dividend cut, below-consensus FY27 EPS ($1.40–$1.50), guided organic declines, and margin compression to 10–10.5% versus sector staples at mid-teens. Compared with Consumer Staples and Food peers, Conagra now offers inferior growth, weaker margins, higher leverage, and diminished income appeal. The CEO transition and “rebuild year” raise execution risk. I see fair value in the $13–14 range, with resistance at $15.50 and stronger overhead at $17; risk-reward is skewed to the downside until evidence of sustained margin recovery emerges.
More Breaking News
Quick Financial Overview
ConAgra Brands Inc. is coming off a tough fiscal year. Q4 FY26 net sales rose 3.6%, but organic sales were flat, showing that volume and real underlying demand remain soft. Adjusted operating margin fell to 11.7%, and adjusted EPS landed at $0.47 for the quarter, feeding into full-year adjusted EPS of $1.72. For FY26, net sales fell 2.9% with organic revenue down 0.4%, while free cash flow dropped about 25% and adjusted EBITDA declined around 17%, signaling clear pressure on profitability and cash generation.
The balance sheet and key ratios confirm a leveraged, low-growth profile. Revenue sits near $11.28B with a price-to-sales ratio around 0.66, which looks cheap on the surface but comes with a total debt-to-equity ratio of 1.14 and a current ratio of 0.9. Returns are weak: recent return on equity is negative on a trailing basis and return on assets is also in negative territory, reflecting the $2.0B impairment. Management cut the annual dividend to $0.70 despite a historical yield near the mid-4% area, choosing deleveraging and reinvestment over cash payouts.
On the tape, CAG has been sliding. The weekly data show price rolling from the mid-$15s down toward the low-$14s, with a recent close near $14.53, pushing the stock under prior $15–$15.50 support. Intraday, the 5‑minute chart reveals heavy selling pressure after the earnings and guidance release, with failed bounces into the $14.80–$14.90 area and persistent lower highs through the session. For short-term traders, $14.90–$15.00 now acts as near-term resistance, while the $14.50 zone is the immediate support to watch for either breakdowns or mean-reversion scalps.
Conclusion
This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.
Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:
- Penny Stocks Trading Guide
- Best Penny Stocks Under $1 to Buy Today
- Top 8 Penny Stocks to Watch on Robinhood
Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:
Leave a reply